HemaQuest Pharmaceuticals (www.HemaQuest.com), established in late 2007, is a San Diego and Seattle-based biopharmaceutical company focused on developing small molecule therapeutics based on its proprietary SCFAD technologies to treat hemoglobin diseases. The Company's investors include Aberdare Ventures, De Novo Ventures, Forward Ventures, Latterell Venture Partners and Lilly Ventures.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/12/12 | $13,000,000 | Series B |
Aberdare Ventures Latterell Venture Partners | undisclosed |
